VivoSeq
Other

Cortisol

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Cortisol is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

11

clinical trials

Completed6 · 55%
Unknown status4 · 36%
Active, not recruiting1 · 9%

Trial Activity

11 trials

Effects of Metyrapone in Patients With Hypercortisolism
Active, not recruiting··N/A·NCT05255900·20 enrolled
Effect of Exenatide on Cortisol Secretion
Completed·UUniversity of Tartu·Phase 4·NCT03160261·10 enrolled
Cortisol and Nutritional Sympathetic Responsiveness
Unknown status··Phase 4·NCT01620684·24 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)